Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Ibarra eterna
None
Taxonomic revision of the olingos (Bassaricyon), with description of a new species, the Olinguito
This paper presents the first comprehensive taxonomic revision of the olingos, Bassaricyon, based on most available museum specimens, with data derived from anatomy, mitochondrial and nuclear DNA, fieldwork, and geographic range modeling. Olingos are forest-living, arboreal, nocturnal, frugivorous, and solitary, and have one young at a time. Four olingo species can be recognized, including a Central American species (B. gabbii) and lowland species with eastern, cis-Andean (B. alleni) and western, trans-Andean (B. medius) distributions. Surprisingly, the sister lineage to all previously described species of Bassaricyon is an Andean cloud forest species, which we call the Olinguito, that has never been previously described. Bassaricyon neblina sp. n., en-demic to Colombia and Ecuador, is the smallest living member of the family Procyonidae and the first new species of Carnivora named in the American continents in 35 years. We describe four subspecies of Olinguito across the Northern Andes.
Innovation in Pharmacy: Advances and Perspectives. September 2018
This book contains the summaries of the "Innovation in Pharmacy: Advances and Perspectives" that took place in Salamanca (Spain) in September 2018. The early science of chemistry and microbiology were the source of most drugs until the revolution of genetic engineering in the mid 1970s. Then biotechnology made available novel protein agents such as interferons, blood factors and monoclonal antibodies that have changed the modern pharmacy. Over the past year, a new pharmacy of oligonucleotides has emerged from the science of gene expression such as RNA splicing and RNA interference. The ability to design therapeutic agents from genomic sequences will transform treatment for many diseases. The...
SEC Docket
None
Imbabura, telúrica
None
